Corgenix Medical Corp announced the issuance of one new European patent for the company’s AtherOx (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).
Read MoreOvaGene Oncology Inc, a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced the opening of its new clinical and research laboratory in Irvine, Calif.
Read MoreA test developed by the US Centers for Disease Control and Prevention to diagnose human infections with the 2009 H1N1 influenza virus (formerly known as swine flu or pandemic H1N1 flu) was authorized for use today by the FDA.
Read MoreCardioGenics Holdings Inc announced the selection of four sites for clinical testing of its patented QL Care analyzer, a portable diagnostic platform designed to produce test results with central lab-like accuracy in 15 minutes using whole blood.
Read MoreAbbott’s ARCHITECT HIV Ag/Ab Combo assay is the first test approved in the United States that can simultaneously detect both HIV antigen and antibodies.
Read More